Introduction {#sec1-1}
============

Colorectal cancer (CRC) is one of the Indonesian major health issues causing approximately 15.1 age-standardised mortality per 100,000 population a year (Ferlay et al., 2015). The aetiology of sporadic CRC is predominately rooted by dietary and lifestyle behaviours. Some studies revealed that high dietary intake of fibre and calcium have been associated with lower CRC risk (Haggar and Boushey, 2009; Murphy et al., 2012; Ahearn et al., 2012).

Edible canna or Ganyong (*Canna edulis* Kerr., family Cannaceae) is a crude herbaceous flowering plant with large small banana-like leave. It has a bright yellow, orange or red coloured flower. It grows from large, thick and underground rootstock that form a tuber and about 90 centimetres to 3 meters tall. This tuber contains various phytochemicals that has been used in traditional medicine for the treatment of many complaints. It also has high dietary fibre and calcium content (Al-Snafi, 2015). However, there was limited available information regarding the role of Ganyong as CRC preventing agent.

Dietary fibre has a protective effect against CRC by increasing faecal bulking, reducing inflammation and shortening the contact time between the carcinogenic agent and the gut (Lima and Gomes-da-Silva, 2005; Suckow et al., 2006; Kaczmarczyk et al., 2012). During the digestion process, the dietary fibre could be transformed to butyrate towards fermentation. Butyrate acts as histone deacetylase inhibitors agent (HDACi); a mechanism by which not only reducing proliferation and β-catenin expression but also increasing apoptosis and Adenomatous Polyposis Coli (APC) expression (Bordonaro at al., 2011; Zhao et al., 2014). In accordance, calcium reduces inflammation, β-catenin and increases E-cadherin, MutL Homolog 1 (MLH1) and MutS Homolog 2 (MLH2) expression (Sidelnikov et al., 2010; Yang et al., 2014).

Azoxymethane (AOM) is a carcinogenic compound. The combination of AOM and dextran sodium sulphate (DSS) has been widely used for CRC induction in vivo study. The pathogenesis of AOM/DSS-induced CRC often linked to APC and Inducible Nitric Oxide Synthase (iNOS). Adenomatous Polyposis Coli inhibits β-catenin thus reduces cell proliferation while iNOS acts as an inflammatory agent that can initiate tumour-associated inflammation (Saad et al., 2012; Chen et al., 2013). The aim of this study was to evaluate the role of APC and iNOS expression in AOM/DSS-induced rat treated with Ganyong.

Materials and Methods {#sec1-2}
=====================

Materials {#sec2-1}
---------

Fresh Ganyong's (*Canna edulis* Kerr.) tubers were supplied by local producers from Sukoharjo, Indonesia. A specimen voucher was deposited at herbarium unit in Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia. Samples were prepared by drying thick chips of the tubers in an oven (30 °C, 40 h). Subsequently, these dried chips were milled to produce powdered flours. The powdered Ganyong tubers were consumed as a food supplement.

Subject description {#sec2-2}
-------------------

Thirty male Wistar rats were divided into 5 equal groups: (1) the control group, (2) positive control cancer group with AOM/DSS induction only, (3) treated with 5% Ganyong, (4) treated with 10% Ganyong and (5) treated with 20% Ganyong. Single 10 mg/kg BW dose of AOM in 10% buffer saline was given intraperitoneally to non-normal group in the fourth week of the experiment. Animals were also administered 2% DSS drink in the week of the experiment.

Wistar rats were obtained from Cancer Research Centre Laboratory, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia. All animals were placed individually and maintained under standard conditions of temperature (25 ± 1.0 °C), humidity (55 ± 10%), 12-h light/dark cycle with free access of rat's standard food (Comfeed Industries Ltd) and water ad libitum. All equipment that were included in handling and sacrificing were in accordance to European Council Legislation for The Protection of Experimental Animals. All of the animal treatment procedures were approved by Medical and Health Research Ethics Committee (Faculty of Medicine, Universitas Gadjah Mada), decision number KE/FK/557/EC.

Tissue processing {#sec2-3}
-----------------

After 14 weeks of treatment, colon tissue of Wistar rats were collected and embedded in paraffin wax using Swiss roll technique (Colnot et al., 2004). Sections were sliced for 5 and 4 µm of thickness used for histological and immunohistochemical staining respectively.

Histological staining {#sec2-4}
---------------------

Five-micron paraffin sections were stained with Haematoxylin-Eosin for examining morphological changes of colon tissue according to previous study (Bourroul et al., 2013).

Immunohistochemical staining of APC and iNOS {#sec2-5}
--------------------------------------------

Primary antibody anti-APC (Biorbyt, orb10109) 0.5 mg/ml and anti-iNOS (ABCAM, ab15323) 0.052 mg/ml in buffer saline were used in this study. Immunostaining was performed using Starr Trek™ Universal HRP Detection System kit (Biocare, Concord, CA, USA) at room temperature according to the manufacturer instruction. Peroxidase activity were detected by incubating samples with 3,3 Diaminobenzedine (DAB) chromogen substrate. It considered positive when there is a formation of a brown precipitate. Finally, sections were counterstained with haematoxylin and DPX mounted.

Evaluation of immunohistochemical staining {#sec2-6}
------------------------------------------

For evaluation, five and seven areas of each APC and iNOS section were selected randomly in 400X magnification, respectively. Each area was observed by two blinded observers. Data were collected from the modified proportion (Bourroul et al., 2013) sum of positive cell per total cell in the same area with given formula:

Proportion = (Total positive cells/ Total cells) x 100%

Data analysis {#sec2-7}
-------------

The data were shown in median (minimum-maximum) proportion. Data were collected from the mean of 5 and 7 images for APC and iNOS expression respectively. Normality test used Saphiro-Wilk test. APC and iNOS expression were tested by Kruskal-Wallis test followed by Dunn's test for group comparison. A median difference considered significant when p\<0.05 (SPSS statistics version 24).

Results {#sec1-3}
=======

Histopathological Status of Rat Colon {#sec2-8}
-------------------------------------

Thirty paraffin sections of colon tissue from 30 male Wistar rats were used in this research. The histopathological status of CRC was divided into normal, colitis, dysplasia and adenocarcinoma and established under experienced pathologist supervision (Bourroul et al., 2013). Histopathological status of rat colon was summarized in [Table 1](#T1){ref-type="table"}.

###### 

The Profile of APC and iNOS Expression among Groups

  Groups                n                Histophatology (%)                                                                                         APC Expression                                                                        iNOS Expression
  --------------------- ---------------- -------------------- ------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------- -------------------------------------
  Normal                6                Normal               100                                                                                   No expression                                                                         No expression
  AOM/DSS               6                Normal               16.7                                                                                  No expression                                                                         No expression
                                         Colitis              33.3                                                                                  Cytoplasmic staining of stromal                                                       Cytoplasmic staining of stromal
                                         Dysplasia            33.3                                                                                  Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cell   Cytoplasmic staining of tumour cell
                                         Adenocarcinoma       16.7                                                                                  Cytoplasmic staining of epithelial and tumour cell                                    Cytoplasmic staining of tumour cell
  5% treated Ganyong    6                Normal               16.7                                                                                  No expression                                                                         No expression
                        Colitis          33.3                 Cytoplasmic staining of stromal                                                       Cytoplasmic staining of stromal                                                       
                        Dysplasia        16.7                 Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cell   Cytoplasmic staining of tumour cell                                                   
                        Adenocarcinoma   33.3                 Cytoplasmic staining of epithelial and tumour cell                                    Cytoplasmic staining of tumour cell                                                   
  10% treated Ganyong   6                Normal               50                                                                                    No expression                                                                         No expression
                        Colitis          33.3                 Cytoplasmic staining of stromal                                                       Cytoplasmic staining of stromal                                                       
                        Dysplasia        16.7                 Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cell   Cytoplasmic staining of tumour cell                                                   
  20% treated Ganyong   6                Normal               33.3                                                                                  No expression                                                                         No expression
                        Colitis          33.3                 Cytoplasmic staining of stromal                                                       Cytoplasmic staining of stromal                                                       
                        Dysplasia        16.7                 Cytoplasmic staining of stromal, stroma-epithelial border cell, and epithelial cell   Cytoplasmic staining of tumour cell                                                   
                        Adenocarcinoma   16.7                 Cytoplasmic staining of epithelial and tumour cell                                    Cytoplasmic staining of tumour cell                                                   

Effect of Ganyong on APC and iNOS expressions {#sec2-9}
---------------------------------------------

Both APC and iNOS were not expressed in normal control group. Meanwhile, APC was expressed in stromal, epithelial and tumour cells whereas iNOS was expressed in stromal and tumour cells ([Figure 1](#F1){ref-type="fig"}) in non-normal control groups. The immunohistochemical staining profile of APC and iNOS were summarised in [Table 1](#T1){ref-type="table"}.

![Haematoxylin-Eosin and Immunohistochemical Staining of Colon Tissue in 400X Magnification. The histopathological of colon was considered as normal, colitis, dysplasia and adenocarcinoma (a-c). APC localisation was shown in stromal, stromal-epithelial border, epithelial and tumour cells (d-f). iNOS localisation was shown in stromal and epithelial cells (g-i). Normal colon (a) was not expressed APC (d) and iNOS (g). Colitis colon (b) expressed APC and iNOS in the cytoplasm of stromal. Dysplasia and adenocarcinoma colon (c) expressed APC in the cytoplasm of stromal, stromal-epithelial border and epithelial cells (f), and expressed iNOS in tumour cell, whereas iNOS expression was in the cytoplasm of tumour cell (g).](APJCP-19-839-g001){#F1}

The strongest expression of APC and iNOS were observed in cancer control group and it was significantly different compared to normal control group (p=0.01). Treated groups showed significantly lower expression of APC than cancer control (p=0.05), especially in the 10% Ganyong group (p=0.02). In contrast, there were no significant differences among all treated groups for iNOS expression compared to cancer control group. The result of Kruskal-Wallis test of both APC and iNOS expression can be seen in [Table 2](#T2){ref-type="table"}.

###### 

Expression of APC and iNOS in Colonic Rat Tissue

  Groups                n   APC                   iNOS                         
  --------------------- --- --------------------- -------- ------------------- --------
  Normal                6   0 (0--0.02)^a^        P=0.01   0 (0--0.394)^c^     P=0.01
  AOM/DSS               6   0.23 (0--0.68)^a,b^            1.11 (0--9.74)^c^   
  5% Treated Ganyong    6   0.03 (0--0.34)                 0.2 (0--2.13)       
  10% Treated Ganyong   6   0 (0--0.05)^b^        p=0.02   1.57 (0--3.34)      
  20% Treated Ganyong   6   0 (0--0.5)                     0.29 (0--1.67)      

Data distribution test with Saphiro-Wilk, p\<0.05. Data showed in median (minimum-maximum); Kruskal-Wallis tests significant, p\<0.05. Dunn's test with significant result are marked with a superscript notation; a,b,c different subscript value in the same column indicates significant difference (p\<0.05).

Discussion {#sec1-4}
==========

The combination of AOM and DSS is commonly used for colon cancer induction in rodent model due to its fast and specific carcinogenic effect (Rosenberg et al., 2009; De Robertis et al., 2011; Zhao et al., 2014). Dextran Sodium Sulphate, an acute inflammatory agent, causes temporary epithelial damage, while the combination of AOM/DSS treatment leads to persistent inflammation (Schultz et al., 2004; Tanaka, 2012; Zeineldin et al., 2014). Furthermore, this combination induces APC mutation and nuclear β-catenin localisation leading to carcinogenesis. The localisation of nuclear β-catenin is correlated with iNOS expression (Takahashi et al., 2000; Neufert et al., 2007). Similar to previous studies, the present study demonstrated a significant difference of APC and iNOS expression between control group and AOM/DSS-induced group (cancer control group).

Generally, the expression of APC in Ganyong treated group was lower than cancer control group. However, the significant difference was only found in the group treated with 10% of Ganyong. The decreasing of CRC-incidence due to high dietary fibre intake was reported before (Chen et al., 2004). Butyrate, the major short chain fatty acid (SCFA) produced from Ganyong's fibre fermentation, was able to inhibit the colorectal carcinogenesis and lowering the CRC risk (Chiaro et al., 2012). It modified any cellular processes through the activation of G-protein couple receptors (GPCRs), HDACi, stimulating the histone acyl transferase and stabilising hypoxia-inducible factor (HIF) (Corrêa-Oliviera et al., 2016). Butyrate also induced p21 expression and inhibited cancer cell proliferation (Chen et al., 2004). However, the fibre must reach the gut then fermented to produce SCFA to be functional as anti-carcinogenic agent (Toden et al., 2014). The role of microbial gut was also important in order to increase the rate of fermentation (Louis et al., 2014). On the other hand, butyrate from *Anaerostipes hadrus* BPB5 fermentation aggravated the colitis by increasing lipopolysaccharide producer (Zhang et al., 2015).

The dose dependent effect of Ganyong administration was implied in this study. The elevation of Ganyong administration decreased the mutant APC expression due to the increasing of butyrate fermentation rate (Chen et al., 2004). Nonetheless, the expression of APC in 20% Ganyong treated groups was tended to increase. It was assumed that the overproduction of butyrate might have led to butyrate resistance phenomenon (Garland et al., 2006). The cell resisted the anti-proliferative effect of HDACi from butyrate (Bordonaro et al., 2011). Moreover, the anti-proliferative effect has not been expressed by all types of butyrate. Iso-butyrate was reported to have a proliferative effect (Chen et al., 2004).

Ganyong is reported as a good source of calcium. One thousand eight hundred mg of calcium per day is needed to prevent CRC (Chiaro et al., 2011). Calcium was known as an anti-inflammatory agent through its binding to the bile acids. The present study showed that calcium only binds bile acids specifically from fat intake (Fedirko et al., 2015). Besides being as an anti-inflammatory agent, calcium also plays an important role as a cofactor. This study showed that the expression of iNOS was not significantly different between treated groups and cancer control group. Since iNOS are non-dependent-calcium enzyme (Kiemer and Vollmar, 2001), the non-significant effect of Ganyong in iNOS expression was reasonable.

This research only indicated the correlation between the elevation of mutant APC expression with bad prognosis. It detected in the colitis and increased along the transformation of histopathological status ([Figure 1](#F1){ref-type="fig"}). Previous studies revealed that APC mutation could transformed normal epithelial cell to microadenoma, an early sign of dysplastic condition sequence of adenoma or adenocarcinoma (Fodde et al., 2001; Yamada and Mori, 2007; Harpaz and Polydorides, 2010). Moreover, the restoration of APC re-established the crypt homeostasis (Dow et al., 2015) was assumed that mutant APC expression could be used as a pre-neoplastic biomarker.

The present study shows that calcium and dietary fibre-rich Ganyong has been proved in reducing the CRC risk. Dietary fibre and calcium acts as anti-proliferative agent by reducing mutant APC expression. This present study highlighted the potency of Ganyong as chemopreventive agent for CRC through downregulating of mutant APC.

List of Abbreviations {#sec2-10}
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AOM: Azoxymethane

APC: Adenomatous polyposis coli

BPB5: Butyrate-producing bacteria 5

CRC: Colorectal cancer

DSS: Dextran sodium sulphate

GPCRs: G-protein couple receptors

HDACi: Histone deacetylase inhibitors

HIF: Hypoxia-inducible factors

iNOS: Inducible nitric oxide synthase

MLH1: MutL homolog 1

MLH2: MutS homolog 2

SCFA: Short chain fatty acids
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